Cargando…
Furin Expression in Patients With Psoriasis—A Patient Cohort Endangered to SARS-COV2?
Background: SARS-Cov2 has raised concerns among dermatologists regarding psoriasis and its respective treatments. Comorbidities, which induce the expression of the proprotease furin have been associated with severe course of COVID-19. Furin and angiotensin converting enzyme 2 (ACE2) play a major rol...
Autores principales: | Graier, Thomas, Golob-Schwarzl, Nicole, Weger, Wolfgang, Benezeder, Theresa, Painsi, Clemens, Salmhofer, Wolfgang, Wolf, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902756/ https://www.ncbi.nlm.nih.gov/pubmed/33644099 http://dx.doi.org/10.3389/fmed.2021.624462 |
Ejemplares similares
-
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis
por: Benezeder, Theresa, et al.
Publicado: (2020) -
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
por: Graier, T., et al.
Publicado: (2022) -
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
por: Graier, Thomas, et al.
Publicado: (2020) -
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease)
por: Benezeder, Theresa, et al.
Publicado: (2019) -
SARS-CoV-2 furin cleavage site was not engineered
por: Garry, Robert F.
Publicado: (2022)